Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation

Journal of Immunology

Volumn 167, Issue 1, 2001, Pages 532-541

  Ensminger, S M ^a   Spriewald, B M ^a   Sorense, H V ^a   Witzke, O ^a   Flashman, E G ^a   Bushell, A ^a   Morris, P J ^a   Rose, M L ^a   Rahemtulla, A ^a   Wood, K J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0035399958     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.1.532     Document Type: Article

References (58)

1. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
2. CD40 and CD154 in cell-mediated immunity
3. Activation of human dendritic cells through CD40 cross-linking
4. CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression
5. αβ T cell regulation and CD40 ligand dependence in murine systemic autoimmunity
6. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
7. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
8. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection
9. + T cell tolerance and linked suppression
10. + T cells play a critical role in costimulation blockade-resistant allograft rejection
11. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses
12. + T cells can trigger allograft rejection
13. + T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade
14. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation
15. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity
16. Development of a mouse aortic transplant model of chronic rejection
17. Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse
18. Gene transfer to Schwann cells after peripheral nerve injury: A delivery system for therapeutic agents
19. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation
20. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
21. Monoclonal xenogeneic antibodies to murine cell surface antigens: Identification of novel leukocyte differentiation antigens
22. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1
23. Mechanisms of tolerance induction after intrathymic islet injection: Determination of the fate of alloreactive thymocytes
24. Evidence for immune regulation in the induction of transplantation tolerance: A conditional but limited role for IL-4
25. Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants: Influence of Fas-mediated apoptosis
26. Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: Evidence for tolerogenicity of donor resting B cells in vivo
27. Differential role for competitive reverse transcriptase-polymerase chain reaction and intracellular cytokine staining as diagnostic tools for the assessment of intragraft cytokine profiles in rejecting and nonrejecting heart allografts
28. Constructing polycompetitor cDNAs for quantitative PCR
29. Kinetics of transplant arteriosclerosis in MHC-class I and fully allogeneic aortic allografts
30. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
31. Eosinophil recruitment to the lung in a murine model of allergic inflammation: The role of T cells, chemokines, and adhesion receptors
32. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-γ
33. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts
34. Interferon-γ elicits arteriosclerosis in the absence of leukocytes
35. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis
36. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
37. LEW-to-F344 carotid artery allografts: Analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses
38. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection
39. A critical role for interleukin 4 in activating alloreactive CD4 T cells
40. CD40-gp39 interactions play a critical role during allograft rejection: Suppression of allograft rejection by blockade of the CD40-gp39 pathway
41. + T-cell responses
42. Upregulation and activation of Stat6 precede vascular smooth muscle cell proliferation in carotid artery injury model
43. Preclinical evaluation of recombinant human intelieukin-4
44. Attenuation of allergic airway inflammation in IL-4 deficient mice
45. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses
46. + T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection
47. Role of the eosinophil in chronic vascular rejection of renal allografts
48. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis
49. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma
50. Cytokine generation by eosinophils
51. Transforming growth factor-β in disease: The dark side of tissue repair
52. Chronic remodeling pathology in grafts
53. Transforming growth factor βs and wound healing
54. IL-4-dependent regulation of TGF-α and TGF-β1 expression in human eosinophils
55. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response
56. Chemokine-induced eosinophil recruitment: Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin
57. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils
58. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness